Company intelligence / Profile preview

Paul Capital Healthcare

New York, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Paul Capital Healthcare is a dedicated healthcare investor that provides financing and risk-sharing solutions for pharmaceutical and biotechnology companies, particularly for late-stage drug development. The firm invests through royalties, revenue interests, and debt financing structures.

Industry: Investors

Partnerships

Phase III Development Company S.A.R.L. (P3D) - funded with $100 million for managing and funding Phase III clinical trials in the European Union

Beyond the preview

Go deeper on Paul Capital Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paul Capital Healthcare.

Explore the full profile